[go: up one dir, main page]

FI970745A7 - Dihydropyridiinijohdannaisia bradykiiniantagonisteina - Google Patents

Dihydropyridiinijohdannaisia bradykiiniantagonisteina Download PDF

Info

Publication number
FI970745A7
FI970745A7 FI970745A FI970745A FI970745A7 FI 970745 A7 FI970745 A7 FI 970745A7 FI 970745 A FI970745 A FI 970745A FI 970745 A FI970745 A FI 970745A FI 970745 A7 FI970745 A7 FI 970745A7
Authority
FI
Finland
Prior art keywords
dihydropyridine derivatives
bradykinin antagonists
bradykinin
antagonists
dihydropyridine
Prior art date
Application number
FI970745A
Other languages
English (en)
Swedish (sv)
Other versions
FI970745A0 (fi
Inventor
Fumitaka Ito
Hiroshi Kondo
David L Hageman
Iii John A Lowe
Susumu Nakanishi
Fredric J Vinick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI970745A7 publication Critical patent/FI970745A7/fi
Publication of FI970745A0 publication Critical patent/FI970745A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
FI970745A 1994-08-24 1997-02-21 Dihydropyridiinijohdannaisia bradykiiniantagonisteina FI970745A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/JP1994/001398 WO1996006083A1 (en) 1994-08-24 1994-08-24 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists
PCT/IB1995/000400 WO1996006082A1 (en) 1994-08-24 1995-05-26 Dihydropyridine derivatives as bradykinin antagonists

Publications (2)

Publication Number Publication Date
FI970745A7 true FI970745A7 (fi) 1997-02-21
FI970745A0 FI970745A0 (fi) 1997-02-21

Family

ID=14098614

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970745A FI970745A0 (fi) 1994-08-24 1997-02-21 Dihydropyridiinijohdannaisia bradykiiniantagonisteina

Country Status (21)

Country Link
US (1) US5859011A (fi)
EP (1) EP0777653B1 (fi)
JP (1) JP3001978B2 (fi)
KR (1) KR100235285B1 (fi)
CN (1) CN1087737C (fi)
AT (1) ATE204567T1 (fi)
AU (1) AU689587B2 (fi)
CA (1) CA2198231C (fi)
DE (1) DE69522332T2 (fi)
DK (1) DK0777653T3 (fi)
ES (1) ES2159637T3 (fi)
FI (1) FI970745A0 (fi)
GR (1) GR3036907T3 (fi)
IL (1) IL114968A (fi)
MX (1) MX9701363A (fi)
MY (1) MY115372A (fi)
NO (1) NO970806L (fi)
NZ (1) NZ285155A (fi)
TW (1) TW500722B (fi)
WO (2) WO1996006083A1 (fi)
ZA (1) ZA977057B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4345062A1 (de) * 1993-12-31 1995-07-13 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen
MX9701245A (es) * 1996-02-19 1998-04-30 Pfizer Compuestos de 1,4 dihidropiridina.
TNSN97037A1 (fr) * 1996-02-19 2005-03-15 Pfizer Derives de 1,4 -dihydropyridine, procede pour leur preparation et compositions pharmaceutiques les contenant.
JP3823388B2 (ja) * 1996-09-04 2006-09-20 カシオ計算機株式会社 印刷装置
JPH11106375A (ja) * 1997-08-18 1999-04-20 Pfizer Pharmaceut Inc ブラジキニンアンタゴニストとしての光学的に活性な1,4−ジヒドロピリジン化合物
KR100579792B1 (ko) * 1998-05-13 2006-05-12 동화약품공업주식회사 신규 2,5-피리딘디카복실산 유도체
TR200400220T4 (tr) * 1999-12-10 2004-02-23 Pfizer Inc. Bradikinin antagonistleri olarak, 5 üyeli heteroaril ile ikame edilmiş 1,4-dihidropiridin bileşikleri.
ATE233760T1 (de) * 1999-12-10 2003-03-15 Pfizer Substituierte 1,4-dihydropyridinverbindungen zur verwendung als bradykininantagonisten
EP1110962A1 (en) * 1999-12-10 2001-06-27 Pfizer Inc. Process for preparing 1,4-dihydropyridine compounds
US6653313B2 (en) * 2000-08-10 2003-11-25 Warner-Lambert Company Llc 1,4-dihydropyridine compounds as bradykinin antagonists
RS55977B1 (sr) 2013-06-14 2017-09-29 Dompé Farm S P A Antagonisti receptora za bradikinin i farmaceutske kompozicije koje ih sadrže

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162497A (en) * 1987-09-24 1992-11-10 The Administrators Of The Tulane Educational Fund Bradykinin analogs with non-peptide bond
US5120750A (en) * 1989-01-17 1992-06-09 Synphar Laboratories, Inc. Generation of 1,4-dihydropyridine derivatives
US5610142A (en) * 1992-10-08 1997-03-11 Scios Inc. Bradykinin antagonist pseudopeptide derivatives of substituted 4-keto-1,3,8-triazaspiro[4.5]decan-3-alkanoic acids

Also Published As

Publication number Publication date
JP3001978B2 (ja) 2000-01-24
IL114968A0 (en) 1995-12-08
DK0777653T3 (da) 2001-10-08
GR3036907T3 (en) 2002-01-31
DE69522332T2 (de) 2002-01-03
ZA977057B (en) 1997-02-24
NO970806D0 (no) 1997-02-21
AU689587B2 (en) 1998-04-02
AU2416695A (en) 1996-03-14
MX9701363A (es) 1997-05-31
NZ285155A (en) 1998-06-26
US5859011A (en) 1999-01-12
KR100235285B1 (ko) 2000-02-01
WO1996006082A1 (en) 1996-02-29
NO970806L (no) 1997-04-21
ATE204567T1 (de) 2001-09-15
CA2198231A1 (en) 1996-02-29
CN1156449A (zh) 1997-08-06
CA2198231C (en) 1999-12-07
CN1087737C (zh) 2002-07-17
EP0777653A1 (en) 1997-06-11
MY115372A (en) 2003-05-31
IL114968A (en) 1999-08-17
ES2159637T3 (es) 2001-10-16
FI970745A0 (fi) 1997-02-21
WO1996006083A1 (en) 1996-02-29
DE69522332D1 (de) 2001-09-27
EP0777653B1 (en) 2001-08-22
KR970705555A (ko) 1997-10-09
TW500722B (en) 2002-09-01
JPH09510992A (ja) 1997-11-04

Similar Documents

Publication Publication Date Title
ID18003A (id) Antagonis muskarinik
DE69735712D1 (de) Aryl-pyrimidin-derivate
ATE261942T1 (de) 6-phenylpyridinderivate
ATE215950T1 (de) Carbolinderivate
FI955184A7 (fi) Bentsyylipiperidiinijohdannaiset
DE69717274D1 (de) Eruptionskreuz
DE59508427D1 (de) 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate
DE69707782D1 (de) 4-Hydroxypiperidinderivate
PT1037892E (pt) Derivados de piperidina
NO981946D0 (no) Imidazoquinazolin-derivater
FI950089A7 (fi) Dioksosyklobuteenijohdannaiset angiotensiini-II-antagonisteina
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
FI970745A7 (fi) Dihydropyridiinijohdannaisia bradykiiniantagonisteina
EE9900182A (et) 2-metoksüfenüülpiperasiini derivaadid
NO992302L (no) Piperidin-derivater
FI954614A7 (fi) Imidatsolokinoksalinonijohdannaiset EAA-antagonisteina
ATE205830T1 (de) 4-hydroxypiperidinderivate
ITMI941099A0 (it) Derivati chinolinici
DE69724941D1 (de) Aminopyridin-derivate
BR9503042A (pt) Composto de polialquilpiperidina
DE59509209D1 (de) Diphenyloxazolin-derivate
ATE220676T1 (de) 1,4-dihydropyridin-verbindungen als bradykinin- antagonisten
FI965181L (fi) Polyalkoholi-peptidijohdannaiset
IS5077A (is) Öragna form tetrahýdrópýrídínafleiðu
NO20001778L (no) Substituerte piperidinderivater

Legal Events

Date Code Title Description
FD Application lapsed